rs11719996

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004393.6(DAG1):​c.-117+18092T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.286 in 152,008 control chromosomes in the GnomAD database, including 6,745 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.29 ( 6744 hom., cov: 31)
Exomes 𝑓: 0.50 ( 1 hom. )

Consequence

DAG1
NM_004393.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.580

Publications

13 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 3-49488525-T-C is Benign according to our data. Variant chr3-49488525-T-C is described in ClinVar as [Benign]. Clinvar id is 1223881.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DAG1NM_004393.6 linkc.-117+18092T>C intron_variant Intron 1 of 2 ENST00000308775.7 NP_004384.5 Q14118A0A024R2W4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DAG1ENST00000308775.7 linkc.-117+18092T>C intron_variant Intron 1 of 2 1 NM_004393.6 ENSP00000312435.2 Q14118

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43501
AN:
151884
Hom.:
6737
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.257
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.0588
Gnomad SAS
AF:
0.224
Gnomad FIN
AF:
0.472
Gnomad MID
AF:
0.308
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.292
GnomAD4 exome
AF:
0.500
AC:
4
AN:
8
Hom.:
1
AF XY:
0.667
AC XY:
4
AN XY:
6
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
3
AN:
6
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.286
AC:
43526
AN:
152000
Hom.:
6744
Cov.:
31
AF XY:
0.289
AC XY:
21489
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.257
AC:
10664
AN:
41452
American (AMR)
AF:
0.216
AC:
3302
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
1601
AN:
3472
East Asian (EAS)
AF:
0.0591
AC:
306
AN:
5174
South Asian (SAS)
AF:
0.225
AC:
1084
AN:
4820
European-Finnish (FIN)
AF:
0.472
AC:
4984
AN:
10552
Middle Eastern (MID)
AF:
0.308
AC:
90
AN:
292
European-Non Finnish (NFE)
AF:
0.305
AC:
20703
AN:
67962
Other (OTH)
AF:
0.289
AC:
612
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1596
3193
4789
6386
7982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.136
Hom.:
284
Bravo
AF:
0.265
Asia WGS
AF:
0.144
AC:
507
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.3
DANN
Benign
0.40
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11719996; hg19: chr3-49525958; API